FELIPE FRANCISCO BONDAN TUON
Projetos de Pesquisa
Unidades Organizacionais
LIM/46 - Laboratório de Parasitologia Médica, Hospital das Clínicas, Faculdade de Medicina
12 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 12
bookPart Leishmaniose tegumentar(2013) AMATO, Valdir Sabbaga; CAMARGO, Raphael Abegão de; TUON, Felipe Francisco- Fosfomycin in vitro resistance of Escherichia coli from the community(2011) BIONDO, Caroline M.; ROCHA, Jaime L.; TUON, Felipe Francisco
bookPart Meningococcemia(2013) TUON, Felipe Francisco; NEVES, Alan de BritobookPart Febre Amarela(2013) TUON, Felipe Francisco- Case Report: Cutaneous Leishmaniasis in a Rheumatoid Arthritis Patient Receiving Methotrexate(2022) AMATO, Valdir Sabbaga; SOUZA, Regina Maia de; FRANCO, Lucas Augusto Moyses; MARTINS, Roberta Cristina Ruedas; SILVA, Camila Alves Maia da; EMORI, Christini Takemi; CELESTE, Beatriz Julieta; CASTANHEIRA, Gabriel Victor; TUON, Felipe FranciscoThe immunosuppressive effect of methotrexate has rarely been associated with reactivation of cutaneous leishmaniasis. Here we present a case of a cutaneous leishmaniasis patient with atypical clinical symptoms without splenomegaly but with cutaneous manifestations after treatment of rheumatoid arthritis with methotrexate and blood recovery of the parasite. Next-generation sequencing was used to identify Leishmania infantum chagasi in the patient's blood sample.
- Short Report: Can We Use a Lower Dose of Liposomal Amphotericin B for the Treatment of Mucosal American Leishmaniasis?(2011) AMATO, Valdir S.; TUON, Felipe F.; CAMARGO, Raphael A.; SOUZA, Regina M.; SANTOS, Carolina R.; NICODEMO, Antonio C.Liposomal amphotericin B has been used as an alternative treatment of mucosal leishmaniasis, but the optimal dose is not established. We retrospectively reviewed the clinical outcome of eight patients with mucosal leishmaniasis treated with liposomal amphotericin B. The mean total dose was 35 mg/kg (range 24-50 mg/kg), which resulted in the healing of all the lesions in all patients and no recurrences were observed during the follow-up period (mean 25 months; range 7-40 months).
bookPart Leishmanaiose Visceral(2016) AMATO, Valdir Sabbaga; SOUZA, Regina Maia de; BRAZ, Lucia Maria Almeida; CAMARGO, Raphael Abegão de; TUON, Felipe Francisco Bondan; NICODEMO, Elisabeth LimabookPart Paracoccidioidomicose(2013) TELLES FILHO, Flávio de Queiroz; TUON, Felipe Francisco- Leishmania (Viannia) braziliensis identification by PCR in the state of Para, Brazil(2011) BACHA, H. A.; TUON, F. F.; ZAMPIERIC, R. A.; FLOETER-WINTER, L. M.; OLIVEIRA, J.; NICODEMO, A. C.; QUIROGA, M. M.; MASCHERETTI, M.; BOULOS, M.; AMATO, V. S.The incidence of cutaneous leishmaniasis (CL) is increasing and there is limited surveillance of Leishmania species throughout the world. We identified the species associated with CL in a region of Amazonia, an area recognized for its Leishmania species variability. Clinical findings were analyzed and correlated with the species identified in 93 patients. PCR assays were based on small subunit ribosomal DNA (SSU-rDNA) and G6PD, and were performed in a laboratory located 3,500 km away. Leishmania (V.) braziliensis was identified in 53 patients (57%). The other 40 patients (43%) carried a different species (including six cases of L (L) amazonensis). Molecular methods can be employed, using special media, to allow transport to distant laboratories. L (V.) braziliensis is the most common species in the area of Para. The location of ulcers can suggest CL species (C) 2010 Royal Society of Tropical Medicine and Hygiene.
bookPart Leishmaniose visceral(2013) TUON, Felipe Francisco